Panitumumab
Panitumumab (ABX-EGF) is a recombinant human IgG2 monoclonal antibody that binds specifically to the human epidermal growth factor receptor (EGFR). This drug is an antineoplastic agent.
| Trivial name | IGHG2 |
| Catalog Number | TP-080CL |
| Alternative Name(s) | Panitumumab |
| Research Area | Cancer |
| Molecular Formula | N/A |
| CAS# | 339177-26-3 |
| Purity | >90% |
| Size | 1 mg |
| Supplier Page | https://www.creativebiolabs.net/Panitumumab-22418.htm |
| Additional Information | For the treatment of EGFR-expressing, metastatic colorectal carcinoma that is refractory to fluoropyrimidine-, oxaliplatin-, and irinotecan- containing chemotherapy regimens. |